ArticleThe Journal of experimental medicine2014

Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.

Claudio Raimondi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.